Bullous fixed drug eruption induced by fluconazole: Importance of multi-site lesional patch testing

Contact Dermatitis. 2021 May;84(5):350-352. doi: 10.1111/cod.13745. Epub 2020 Dec 6.

Authors

Ky Lyn Tan¹, Ilaria Bisconti¹, Claire Leck¹, Thippeswamy Billahalli¹, Sheena Barnett^{1

2}, Karalasingam Rajakulasingam^{1

2}, Timothy J Watts^{1

3}

Affiliations

¹ Department of Respiratory Medicine & Allergy, Homerton University Hospital NHS Foundation Trust, London, UK.
² Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ National Heart & Lung Institute, Imperial College London, London, UK.

PMID: 33210283
DOI: 10.1111/cod.13745

No abstract available

Keywords: case report; drug patch testing; fixed drug eruption; fluconazole.

Publication types

Case Reports

MeSH terms

Administration, Oral
Adult
Antifungal Agents / adverse effects*
Candidiasis, Vulvovaginal / drug therapy
Drug Eruptions / etiology*
Drug Eruptions / pathology
Female
Fluconazole / administration & dosage
Fluconazole / adverse effects*
Humans
Knee / pathology
Lip / pathology
Patch Tests / methods*

Substances

Antifungal Agents
Fluconazole